<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00668681</url>
  </required_header>
  <id_info>
    <org_study_id>Endo060234</org_study_id>
    <nct_id>NCT00668681</nct_id>
  </id_info>
  <brief_title>Evaluation of EndoRefix Endovascular Delivery System and Staple</brief_title>
  <acronym>EndoRefix</acronym>
  <official_title>Safety Data Collection for Delivery System and Use of Staple in Endovascular Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lombard Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lombard Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is intended to provide data to verify safe delivery of a staple previously
      intended for use in open surgical procedures. A newly modified delivery system will provide
      endovascular access for implantation of a staple during endovascular graft procedures.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Company business decision, IDE closed, no commercialization planned
  </why_stopped>
  <start_date>April 2008</start_date>
  <completion_date type="Anticipated">February 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>AAA Graft Implant for Primary Aneurysm Treatment</condition>
  <condition>AAA Graft Repair to Extend Life of Implant</condition>
  <arm_group>
    <arm_group_label>Endorefix</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Evaluation of EndoRefix Endovascular Delivery System and Staple</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EndoRefix</intervention_name>
    <arm_group_label>Endorefix</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female &gt;21 years of age

          2. Undergoing endovascular stent grafting for AAA repair

          3. Post endovascular stent grafting where stent stabilization is necessary due to stent
             fixation failure and/or persistent endoleak.

        Exclusion Criteria:

          1. Pregnant

          2. Religious, cultural or other objection to the receipt of blood, or blood products.

          3. Unwilling to comply with follow-up schedule

          4. Unwillingness, or inability to provide informed consent to both trila and procedure

          5. Ruptured Aneurysm

          6. Area where staple is to be placed has significant loose thrombus associated with it

          7. Acute or chronic aortic dissection or mycotoc aneurysm

          8. Allergy to device materials

          9. Allergy to or intolerance to use of contrast media or cannot be exposed to suitable
             remedial treatment such as steroids and/or diphenhydramine.

         10. Clinically and morbidly obese such that imaging would be severely adversely affected.

         11. Uncorrectable bleeding abnormality

         12. Inflammatory aneurysm

         13. Connective tissue disease (e.g., Marfans syndrome, Ehlers Danlos syndrome)

         14. Patients with PTFE grafts

         15. Patients with investigational grafts (i.e., those grafts that are not FDA approved)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank Arko, MD</last_name>
    <role>Study Chair</role>
    <affiliation>St. Paul University Hospital, Dallas Texas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Faries, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mount Sinai Hospital, New York</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Louis Sanchez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barnes Jewish Hospital, St. Louis Missouri</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Venkatash Ramaiah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arizona Heart Institute, Phoenix, Arizona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Mewissen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Luke's Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Fillinger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mary Hitchcock Memorial Hospital, Lebanon New Hampshire</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zvonko Krajcer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Lukes Episcopal Hospital, Houston Texas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Will Jordan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama, Birmingham Alabama.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anthony Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida, Gainesville, Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karthikes Kasirajan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University, Atlanta Georgia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Heart Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30368</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mary Hitchcock Memorial Hospital</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Paul University Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Lukes Episcopal Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2008</study_first_submitted>
  <study_first_submitted_qc>April 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2008</study_first_posted>
  <last_update_submitted>October 15, 2012</last_update_submitted>
  <last_update_submitted_qc>October 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 17, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Abdominal Aortic Aneurysm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

